Abstract
Objectives: To analyze the efficacy and adverse events (AEs) of pirfenidone in idiopathic pulmonary fibrosis (IPF) trials. Methods: MEDLINE, Cochrane ......
小提示:本篇文献需要登录阅读全文,点击跳转登录